- April 13, 2020
- February 6, 2021
CLEW announces appointment of Paul Roscoe as CEO
CLEW, a provider of real-time AI analytics platforms for healthcare, today announced that its board of directors has named Paul Roscoe as its new CEO, responsible for leading the growth of CLEW worldwide.
Penn State Health to Pioneer Next-Generation Virtual ICUs with CLEW Medicalโs AI Powered Cloud-based Platform
Bringing virtualICU services in-house and offering them to both owned and referral hospitals in the region, to better manage capacity and address provider shortages driven by prolonged pandemic and burnout.
Equum and CLEW join forces on telehealth services in acute critical care
AI-based clinical decision support tools support more proactive care and increased physician productivity
CLEW Registered for CE Expanding its Commercial Reach in the European market
To improve the efficiency of the European healthcare system, the innovative CLEWICU solution identifies patients with an increased likelihood of being diagnosed with respiratory failure or hemodynamic instability, prioritizes workflow and treatment, and optimizes the allocation of critical care resources
Healthcare industry professionals Ron Greeno and Mike Murphy join CLEW Medical’s Advisory Board
The highly experienced healthcare executives will advise CLEW Medical as the company expands its product offering in North America following FDA 510k approval
CLEW Medical Receives FDA Clearance for AI-Based Predictive Analytics Technology to Support Adult ICU Patient Assessment
CLEWICU is the industry’s first-ever cleared device for predicting the likelihood of patient deterioration up to 8 hours in advance based on hemodynamic instability, enabling earlier evaluation and subsequent care plans
CLEW Receives FDA Emergency Use Authorization (EUA) for its Predictive Analytics Platform in Support of COVID-19 Patients
CLEWICU is the only device authorized by the FDA to provide early identification of patients who are likely to experience respiratory failure or hemodynamic instability, both potentially common but significant complications associated with COVID-19
SHAM the Parent Company of the Relyens Mutual Group Forges 5 Exclusive Technology Partnerships
Relyens forges five exclusive technology partnerships to enhance the operational safety of healthcare professionals and local authorities
Dr. John Halamka Joins CLEW’s Scientific Advisory Board
Prominent healthcare technology pioneer to advise CLEW as the company expands its product offering across the entire continuum of care
CLEW to be featured in a new episode of โInformation Matrix”, with Laurence Fishburne
Featuring healthcare industry experts, the program will show how critical care units are using AI-Machine Learning to deliver true patient value
CLEW – Boosting Clinical Analytics with Machine Learning
CLEW used Google Compute Engine to build a reliable, scalable, cloud-based machine learning platform to develop and train its critical care algorithms.
CLEW teams with Mayo Clinic on Critical Care
The study will focus on the feasibility of using the Israeli startup’s analytics platform to predict patient deterioration from infection.
